TLR9 - toll like receptor 9 Gene

Species: Felis catus

Gene Type: protein coding
Gene ID: 493839

TLR9 Products (1)

mRNA Protein Name
NM_001009285.1 NP_001009285.1 toll-like receptor 9 precursor

TLR9 Protein Structure

PRK15370

PRK15370: cl33128 (27 - 274)

LRR_RI

LRR_RI: sd00033 (42 - 63)

LRR_RI

LRR_RI: sd00033 (64 - 87)

LRR_RI

LRR_RI: sd00033 (88 - 123)

LRR_RI

LRR_RI: sd00033 (124 - 167)

LRR_RI

LRR_RI: sd00033 (168 - 199)

PLN00113

PLN00113: cl33413 (199 - 710)

LRR_RI

LRR_RI: sd00033 (200 - 220)

LRR_RI

LRR_RI: sd00033 (221 - 244)

LRR_RI

LRR_RI: sd00033 (245 - 284)

LRR_RI

LRR_RI: sd00033 (285 - 308)

LRR_RI

LRR_RI: sd00033 (309 - 334)

LRR_RI

LRR_RI: sd00033 (335 - 364)

LRR_RI

LRR_RI: sd00033 (365 - 391)

LRR_RI

LRR_RI: sd00033 (392 - 415)

LRR_RI

LRR_RI: sd00033 (416 - 471)

LRR_RI

LRR_RI: sd00033 (475 - 496)

LRR_RI

LRR_RI: sd00033 (497 - 521)

LRR_RI

LRR_RI: sd00033 (522 - 545)

LRR_RI

LRR_RI: sd00033 (546 - 598)

LRR_RI

LRR_RI: sd00033 (599 - 628)

LRR_RI

LRR_RI: sd00033 (629 - 653)

LRR_RI

LRR_RI: sd00033 (654 - 677)

LRR_RI

LRR_RI: sd00033 (678 - 701)

LRR_8

LRR_8: pfam13855 (700 - 761)

LRR_RI

LRR_RI: sd00033 (702 - 725)

LRR_RI

LRR_RI: sd00033 (726 - 747)

TIR_2

TIR_2: cl23749 (867 - 1010)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 1031 a.a.
Protein Preferred Names Protein Names

toll-like receptor 9

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B1370 Hydroxychloroquine sulfate Inhibitor 99.99% Yes
HY-B1370B (R)-Hydroxychloroquine Inhibitor / Unkown
HY-B1370A (S)-Hydroxychloroquine Inhibitor / Unkown

Clinical Phase

Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Phase
HY-150218 Agatolimod sodium Agonist 99.13% Phase 3
HY-150212 Tilsotolimod Inhibitor 99.46% Phase 3
HY-148511 Vidutolimod Agonist 93.85% Phase 3
HY-150724C ODN 1018 sodium Agonist 97.49% Phase 2
HY-150724 ODN 1018 Agonist 99.28% Phase 2
HY-177617A Bazlitoran sodium Agonist 95.30% Phase 2
HY-177617 Bazlitoran Agonist 95.30% Phase 2
HY-178166 ETI41 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (33)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-146245 ODN 1826 Agonist 99.69% Unkown
HY-146245C ODN 1826 sodium Agonist 99.51% Unkown
HY-146244 Agatolimod Agonist 98.84% Unkown
HY-150741C ODN 2216 sodium Agonist 98.57% Unkown
HY-150741 ODN 2216 Agonist 98.57% Unkown
HY-N0201 Atractylenolide I Antagonist 99.98% Unkown
HY-150743 ODN 2395 Agonist 98.39% Unkown
HY-150726C ODN 1668 sodium Agonist 98.79% Unkown
HY-124603 AT791 Inhibitor 98.77% Unkown
HY-150743C ODN 2395 sodium Agonist 98.20% Unkown
HY-148045 TLR9-IN-1 Inhibitor 99.67% Unkown
HY-12756 E6446 Antagonist 98.78% Unkown
HY-150726 ODN 1668 Agonist 99.03% Unkown
HY-12756A E6446 dihydrochloride Antagonist 99.29% Unkown
HY-150750 ODN M362 Agonist 96.01% Unkown
HY-150217A CpG ODN 10101 sodium Agonist 98.84% Unkown
HY-150217 CpG ODN 10101 Agonist 99.44% Unkown
HY-B1370R Hydroxychloroquine sulfate (Standard) Inhibitor 99.96% Unkown
HY-101929 CU-CPT17e Agonist 98.67% Unkown
HY-150736 ODN 20844 Inhibitor 96.14% Unkown
HY-146245F FAM-labeled ODN 1826 sodium Agonist 98.03% Unkown
HY-114592 M199 Inhibitor 98.55% Unkown
HY-150744 ODN 24888 Inhibitor / Unkown
HY-150745 ODN 24987 Inhibitor / Unkown
HY-178037 TLR9 antagonist 1 Antagonist / Unkown
HY-179474 TSI-13-57 Inhibitor 98.73% Unkown
HY-150219A ODN M326 sodium Inhibitor / Unkown
HY-180507 TLR2/9 antagonist 1 Antagonist / Unkown
HY-179209 TLR9-IN-2 Inhibitor / Unkown
HY-178169 ETI60 Inhibitor 99.51% Unkown
HY-150219 ODN M326 Agonist / Unkown
HY-183079 ENDO12 Inhibitor / Unkown
HY-183400 BIM-46174 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens TLR9 NCBI NCBI:54106